Stock Track | PomDoctor Soars 7.20% in After-Hours Trading Following Successful Nasdaq IPO

Stock Track10-09

PomDoctor (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, saw its stock price surge 7.20% in after-hours trading on Wednesday. This significant uptick follows the company's successful debut on the Nasdaq stock exchange earlier in the day.

The company priced its initial public offering (IPO) at $4.00 per American Depositary Share (ADS), offering 5,000,004 ADSs to raise approximately $20 million in gross proceeds. PomDoctor's shares began trading on the Nasdaq Global Market under the ticker symbol "POM" on October 8, 2025. The strong after-hours performance suggests continued investor enthusiasm following the stock's positive reception during regular trading hours.

PomDoctor's successful IPO and subsequent stock performance reflect investor confidence in the company's business model, which focuses on chronic disease management and pharmaceutical services in China. As the sixth-ranked player in China's Internet hospital market based on the number of contracted doctors, PomDoctor's one-stop platform for medical services has attracted significant attention from market participants. The company's ability to connect patients with doctors and pharmaceutical products efficiently may be a key factor driving investor interest in this newly public entity.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1159914910?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-09 06:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1159914910","market":"nz","top_or_hot":-1,"title":"Stock Track | PomDoctor Soars 7.20% in After-Hours Trading Following Successful Nasdaq IPO","media":"Stock Track","content":"<p>PomDoctor (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, saw its stock price surge 7.20% in after-hours trading on Wednesday. This significant uptick follows the company's successful debut on the Nasdaq stock exchange earlier in the day.</p>\n\n<p>The company priced its initial public offering (IPO) at $4.00 per American Depositary Share (ADS), offering 5,000,004 ADSs to raise approximately $20 million in gross proceeds. PomDoctor's shares began trading on the Nasdaq Global Market under the ticker symbol \"POM\" on October 8, 2025. The strong after-hours performance suggests continued investor enthusiasm following the stock's positive reception during regular trading hours.</p>\n\n<p>PomDoctor's successful IPO and subsequent stock performance reflect investor confidence in the company's business model, which focuses on chronic disease management and pharmaceutical services in China. As the sixth-ranked player in China's Internet hospital market based on the number of contracted doctors, PomDoctor's one-stop platform for medical services has attracted significant attention from market participants. The company's ability to connect patients with doctors and pharmaceutical products efficiently may be a key factor driving investor interest in this newly public entity.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | PomDoctor Soars 7.20% in After-Hours Trading Following Successful Nasdaq IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | PomDoctor Soars 7.20% in After-Hours Trading Following Successful Nasdaq IPO\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-10-09 06:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>PomDoctor (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, saw its stock price surge 7.20% in after-hours trading on Wednesday. This significant uptick follows the company's successful debut on the Nasdaq stock exchange earlier in the day.</p>\n\n<p>The company priced its initial public offering (IPO) at $4.00 per American Depositary Share (ADS), offering 5,000,004 ADSs to raise approximately $20 million in gross proceeds. PomDoctor's shares began trading on the Nasdaq Global Market under the ticker symbol \"POM\" on October 8, 2025. The strong after-hours performance suggests continued investor enthusiasm following the stock's positive reception during regular trading hours.</p>\n\n<p>PomDoctor's successful IPO and subsequent stock performance reflect investor confidence in the company's business model, which focuses on chronic disease management and pharmaceutical services in China. As the sixth-ranked player in China's Internet hospital market based on the number of contracted doctors, PomDoctor's one-stop platform for medical services has attracted significant attention from market participants. The company's ability to connect patients with doctors and pharmaceutical products efficiently may be a key factor driving investor interest in this newly public entity.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"POM","symbol_name":"石榴云医","start_time":0,"source_url":"","article_id":"1159914910","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1159914910","pubTimestamp":1759960831,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"PomDoctor (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, saw its stock price surge 7.20% in after-hours trading on Wednesday. This significant uptick follows...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"POM":"石榴云医"},"translate_title":"个股追踪|纳斯达克IPO成功后PomDoctor盘后大涨7.20%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"POM":1},"content_text":"PomDoctor (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, saw its stock price surge 7.20% in after-hours trading on Wednesday. This significant uptick follows the company's successful debut on the Nasdaq stock exchange earlier in the day.\nThe company priced its initial public offering (IPO) at $4.00 per American Depositary Share (ADS), offering 5,000,004 ADSs to raise approximately $20 million in gross proceeds. PomDoctor's shares began trading on the Nasdaq Global Market under the ticker symbol \"POM\" on October 8, 2025. The strong after-hours performance suggests continued investor enthusiasm following the stock's positive reception during regular trading hours.\nPomDoctor's successful IPO and subsequent stock performance reflect investor confidence in the company's business model, which focuses on chronic disease management and pharmaceutical services in China. As the sixth-ranked player in China's Internet hospital market based on the number of contracted doctors, PomDoctor's one-stop platform for medical services has attracted significant attention from market participants. The company's ability to connect patients with doctors and pharmaceutical products efficiently may be a key factor driving investor interest in this newly public entity.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1159914910","isCrawlerRequest":true}